{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:07:25Z","timestamp":1790251645432,"version":"4.1.0"},"publisher-location":"Cham","reference-count":183,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030573775","type":"print"},{"value":"9783030573782","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_340","type":"book-chapter","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T05:02:29Z","timestamp":1577682149000},"page":"475-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Drugs Causing Bone Loss"],"prefix":"10.1007","author":[{"given":"Peter","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"340_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archinternmed.2011.20","volume":"171","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B, Eiken P, Eastell R (2011) Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 171:998\u20131004. https:\/\/doi.org\/10.1001\/archinternmed.2011.20","journal-title":"Arch Intern Med"},{"key":"340_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/bjsports-2018-099723","volume":"53","author":"KE Ackerman","year":"2019","unstructured":"Ackerman KE, Singhal V, Baskaran C et al (2019) Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial. Br J Sports Med 53:229\u2013236. https:\/\/doi.org\/10.1136\/bjsports-2018-099723","journal-title":"Br J Sports Med"},{"key":"340_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2174\/1874325001711010777","volume":"11","author":"AN Ahmad","year":"2017","unstructured":"Ahmad AN, Ahmad SN, Ahmad N (2017) HIV infection and bone abnormalities. Open Orthop J 11:777\u2013784. https:\/\/doi.org\/10.2174\/1874325001711010777","journal-title":"Open Orthop J"},{"key":"340_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/03007995.2016.1174841","volume":"32","author":"M Alba","year":"2016","unstructured":"Alba M, Xie J, Fung A, Desai M (2016) The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus. Curr Med Res Opin 32:1375\u20131385. https:\/\/doi.org\/10.1080\/03007995.2016.1174841","journal-title":"Curr Med Res Opin"},{"key":"340_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1210\/js.2017-00102","volume":"1","author":"O Altayar","year":"2017","unstructured":"Altayar O, Al Nofal A, Carranza Leon BG et al (2017) Treatments to prevent bone loss in functional hypothalamic amenorrhea: a systematic review and meta-analysis. J Endocr Soc 1:500\u2013511. https:\/\/doi.org\/10.1210\/js.2017-00102","journal-title":"J Endocr Soc"},{"key":"340_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00198-015-3411-8","volume":"27","author":"ML Avila","year":"2016","unstructured":"Avila ML, Pullenayegum E, Williams S et al (2016) Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study. Osteoporos Int 27:1547\u20131557. https:\/\/doi.org\/10.1007\/s00198-015-3411-8","journal-title":"Osteoporos Int"},{"key":"340_CR7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3899\/jrheum.170513","volume":"44","author":"JF Baker","year":"2017","unstructured":"Baker JF, Long J, Mostoufi-Moab S et al (2017) Muscle deficits in rheumatoid arthritis contribute to inferior cortical bone structure and trabecular bone mineral density. J Rheumatol 44:1777\u20131785. https:\/\/doi.org\/10.3899\/jrheum.170513","journal-title":"J Rheumatol"},{"key":"340_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1203\/01.PDR.0000155943.07244.04","volume":"57","author":"C Barnes","year":"2005","unstructured":"Barnes C, Newall F, Ignjatovic V et al (2005) Reduced bone density in children on long-term warfarin. Pediatr Res 57:578\u2013581. https:\/\/doi.org\/10.1203\/01.PDR.0000155943.07244.04","journal-title":"Pediatr Res"},{"key":"340_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/pds.3234","volume":"21","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, Gallagher AM, van Staa T-P et al (2012a) Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiol Drug Saf 21:507\u2013514. https:\/\/doi.org\/10.1002\/pds.3234","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"340_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00223-012-9591-8","volume":"90","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, Vestergaard P, Gallagher AM et al (2012b) Risk of fracture with thiazolidinediones: disease or drugs? Calcif Tissue Int 90:450\u2013457. https:\/\/doi.org\/10.1007\/s00223-012-9591-8","journal-title":"Calcif Tissue Int"},{"key":"340_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.trsl.2012.08.006","volume":"161","author":"GR Beck","year":"2013","unstructured":"Beck GR, Khazai NB, Bouloux GF et al (2013) The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes. Transl Res 161:145\u2013155. https:\/\/doi.org\/10.1016\/j.trsl.2012.08.006","journal-title":"Transl Res"},{"key":"340_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40695-018-0035-0","volume":"4","author":"ME Beksinska","year":"2018","unstructured":"Beksinska ME, Kleinschmidt I, Smit JA (2018) Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status. Womens Midlife Health 4:6. https:\/\/doi.org\/10.1186\/s40695-018-0035-0","journal-title":"Womens Midlife Health"},{"key":"340_CR13","unstructured":"Beljan JR, Hellewell AB (1977) The effect of chronic heparin administration on the mineralization of an experimental osseous defect. Clin Orthop Relat Res:205\u2013207"},{"key":"340_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","volume":"21","author":"SA Beniczky","year":"2012","unstructured":"Beniczky SA, Viken J, Jensen LT, Andersen NB (2012) Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure 21:471\u2013472. https:\/\/doi.org\/10.1016\/j.seizure.2012.04.002","journal-title":"Seizure"},{"key":"340_CR15","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00125-015-3660-2","volume":"58","author":"EO Billington","year":"2015","unstructured":"Billington EO, Grey A, Bolland MJ (2015) The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis. Diabetologia 58:2238\u20132246. https:\/\/doi.org\/10.1007\/s00125-015-3660-2","journal-title":"Diabetologia"},{"key":"340_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/02841860802001467","volume":"47","author":"NH Bjarnason","year":"2008","unstructured":"Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P (2008) Adverse bone effects during pharmacological breast cancer therapy. Acta Oncol 47:747\u2013754. https:\/\/doi.org\/10.1080\/02841860802001467","journal-title":"Acta Oncol"},{"key":"340_CR17","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00198-012-2226-0","volume":"24","author":"K Bleicher","year":"2013","unstructured":"Bleicher K, Cumming RG, Naganathan V et al (2013) Predictors of the rate of BMD loss in older men: findings from the CHAMP study. Osteoporos Int 24:1951\u20131963. https:\/\/doi.org\/10.1007\/s00198-012-2226-0","journal-title":"Osteoporos Int"},{"key":"340_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00404-009-0936-0","volume":"280","author":"N Bozkurt","year":"2009","unstructured":"Bozkurt N, Erdem M, Yilmaz E et al (2009) The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet 280:381\u2013387. https:\/\/doi.org\/10.1007\/s00404-009-0936-0","journal-title":"Arch Gynecol Obstet"},{"key":"340_CR19","first-page":"1489","volume":"24","author":"LM Buckley","year":"1997","unstructured":"Buckley LM, Leib ES, Cartularo KS et al (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24:1489\u20131494","journal-title":"J Rheumatol"},{"key":"340_CR20","first-page":"255","volume":"28","author":"SD Bulut","year":"2016","unstructured":"Bulut SD, Bulut S, Atalan DG et al (2016) The effect of antipsychotics on bone mineral density and sex hormones in male patients with schizophrenia. Psychiatr Danub 28:255\u2013262","journal-title":"Psychiatr Danub"},{"key":"340_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2008.07.001","volume":"39","author":"A Cansu","year":"2008","unstructured":"Cansu A, Yesilkaya E, Serdaro\u011flu A et al (2008) Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 39:266\u2013271. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2008.07.001","journal-title":"Pediatr Neurol"},{"key":"340_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s002239900585","volume":"64","author":"LD Carbone","year":"1999","unstructured":"Carbone LD, Kaeley G, McKown KM et al (1999) Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64:100\u2013101","journal-title":"Calcif Tissue Int"},{"key":"340_CR23","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","volume":"18","author":"LD Carbone","year":"2003","unstructured":"Carbone LD, Tylavsky FA, Cauley JA et al (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18:1795\u20131802. https:\/\/doi.org\/10.1359\/jbmr.2003.18.10.1795","journal-title":"J Bone Miner Res"},{"key":"340_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-0404.2008.01148.x","volume":"120","author":"Y Cetinkaya","year":"2009","unstructured":"Cetinkaya Y, Kurtulmu\u015f YS, Tutkavul K, Tireli H (2009) The effect of oxcarbazepine on bone metabolism. Acta Neurol Scand 120:170\u2013175. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01148.x","journal-title":"Acta Neurol Scand"},{"key":"340_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/1806-9282.64.05.469","volume":"64","author":"PYA Cezarino","year":"2018","unstructured":"Cezarino PYA, Sim\u00f5es RDS, Baracat EC, Soares JM Jr (2018) Are women living with HIV prone to osteoporosis in postmenopause? A systematic review. Rev Assoc Med Bras 64:469\u2013473. https:\/\/doi.org\/10.1590\/1806-9282.64.05.469","journal-title":"Rev Assoc Med Bras"},{"key":"340_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188454","volume":"12","author":"Y-M Chen","year":"2017","unstructured":"Chen Y-M, Chen H-H, Huang W-N et al (2017) Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS One 12:e0188454. https:\/\/doi.org\/10.1371\/journal.pone.0188454","journal-title":"PLoS One"},{"key":"340_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11657-018-0537-2","volume":"13","author":"W Chen","year":"2018","unstructured":"Chen W, Johnson KM, FitzGerald JM et al (2018) Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study. Arch Osteoporos 13:116. https:\/\/doi.org\/10.1007\/s11657-018-0537-2","journal-title":"Arch Osteoporos"},{"key":"340_CR28","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.2147\/DDDT.S179568","volume":"12","author":"L Cheng","year":"2018","unstructured":"Cheng L, Zhang K, Zhang Z (2018) Effectiveness of thiazides on serum and urinary calcium levels and bone mineral density in patients with osteoporosis: a systematic review and meta-analysis. Drug Des Devel Ther 12:3929\u20133935. https:\/\/doi.org\/10.2147\/DDDT.S179568","journal-title":"Drug Des Devel Ther"},{"key":"340_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.6118\/jmm.2016.22.3.174","volume":"22","author":"YH Cho","year":"2016","unstructured":"Cho YH, Um MJ, Kim SJ et al (2016) Raloxifene administration in women treated with long term gonadotropin-releasing hormone agonist for severe endometriosis: effects on bone mineral density. J Menopausal Med 22:174\u2013179. https:\/\/doi.org\/10.6118\/jmm.2016.22.3.174","journal-title":"J Menopausal Med"},{"key":"340_CR30","first-page":"317","volume":"48","author":"I-J Chou","year":"2007","unstructured":"Chou I-J, Lin K-L, Wang H-S, Wang C-J (2007) Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan 48:317\u2013322","journal-title":"Acta Paediatr Taiwan"},{"key":"340_CR31","first-page":"336","volume":"26","author":"A Ciccullo","year":"2018","unstructured":"Ciccullo A, D\u2019Avino A, Lassandro AP et al (2018) Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine\/dolutegravir dual therapy: preliminary results from clinical practice. Infez Med 26:336\u2013340","journal-title":"Infez Med"},{"key":"340_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/TCRM.S79409","volume":"11","author":"F Coluzzi","year":"2015","unstructured":"Coluzzi F, Pergolizzi J, Raffa RB, Mattia C (2015) The unsolved case of \u201cbone-impairing analgesics\u201d: the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag 11:515\u2013523. https:\/\/doi.org\/10.2147\/TCRM.S79409","journal-title":"Ther Clin Risk Manag"},{"key":"340_CR33","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s40618-018-0964-3","volume":"41","author":"F Coluzzi","year":"2018","unstructured":"Coluzzi F, Billeci D, Maggi M, Corona G (2018) Testosterone deficiency in non-cancer opioid-treated patients. J Endocrinol Investig 41:1377\u20131388. https:\/\/doi.org\/10.1007\/s40618-018-0964-3","journal-title":"J Endocrinol Investig"},{"key":"340_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jbmr.3665","volume":"34","author":"FM Conesa-Buend\u00eda","year":"2019","unstructured":"Conesa-Buend\u00eda FM, Llamas-Granda P, Larra\u00f1aga-Vera A et al (2019) Tenofovir causes bone loss via decreased bone formation and increased bone resorption, which can be counteracted by dipyridamole in mice. J Bone Miner Res 34:923\u2013938. https:\/\/doi.org\/10.1002\/jbmr.3665","journal-title":"J Bone Miner Res"},{"key":"340_CR35","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1111\/j.1528-1167.2009.02082.x","volume":"50","author":"G Coppola","year":"2009","unstructured":"Coppola G, Fortunato D, Auricchio G et al (2009) Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia 50:2140\u20132146. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02082.x","journal-title":"Epilepsia"},{"key":"340_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/QAI.0000000000001903","volume":"80","author":"D Costagliola","year":"2019","unstructured":"Costagliola D, Potard V, Lang S et al (2019) Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: a case-control study nested within the French hospital database on HIV (FHDH-ANRS CO4). J Acquir Immune Defic Syndr 80:214\u2013223. https:\/\/doi.org\/10.1097\/QAI.0000000000001903","journal-title":"J Acquir Immune Defic Syndr"},{"key":"340_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1089\/jwh.2004.13.939","volume":"13","author":"C Crandall","year":"2004","unstructured":"Crandall C (2004) Vitamin A intake and osteoporosis: a clinical review. J Women\u2019s Health 13:939\u2013953. https:\/\/doi.org\/10.1089\/jwh.2004.13.939","journal-title":"J Women\u2019s Health"},{"key":"340_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jped.2018.05.011","volume":"95","author":"CB da Rizzo","year":"2018","unstructured":"da Rizzo CB, Goldberg TBL, Biason TP et al (2018) One-year adolescent bone mineral density and bone formation marker changes through the use or lack of use of combined hormonal contraceptives. J Pediatr 95:567\u2013574. https:\/\/doi.org\/10.1016\/j.jped.2018.05.011","journal-title":"J Pediatr"},{"key":"340_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0002-9378(13)90457-9","volume":"170","author":"TC Dahlman","year":"1994","unstructured":"Dahlman TC, Sj\u00f6berg HE, Ringertz H (1994) Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 170:1315\u20131320","journal-title":"Am J Obstet Gynecol"},{"key":"340_CR40","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C de Laet","year":"2005","unstructured":"de Laet C, Kanis JA, Od\u00e9n A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330\u20131338. https:\/\/doi.org\/10.1007\/s00198-005-1863-y","journal-title":"Osteoporos Int"},{"key":"340_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1824-7288-38-56","volume":"38","author":"R di Mase","year":"2012","unstructured":"di Mase R, Cerbone M, Improda N et al (2012) Bone health in children with long-term idiopathic subclinical hypothyroidism. Ital J Pediatr 38:56. https:\/\/doi.org\/10.1186\/1824-7288-38-56","journal-title":"Ital J Pediatr"},{"key":"340_CR42","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","volume":"167","author":"SJ Diem","year":"2007","unstructured":"Diem SJ, Blackwell TL, Stone KL et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167:1240\u20131245. https:\/\/doi.org\/10.1001\/archinte.167.12.1240","journal-title":"Arch Intern Med"},{"key":"340_CR43","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1210\/jc.2013-1971","volume":"98","author":"SJ Diem","year":"2013","unstructured":"Diem SJ, Ruppert K, Cauley JA et al (2013) Rates of bone loss among women initiating antidepressant medication use in midlife. J Clin Endocrinol Metab 98:4355\u20134363. https:\/\/doi.org\/10.1210\/jc.2013-1971","journal-title":"J Clin Endocrinol Metab"},{"key":"340_CR44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","volume":"386","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2015","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386:1341\u20131352. https:\/\/doi.org\/10.1016\/S0140-6736(15)61074-1","journal-title":"Lancet"},{"key":"340_CR45","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","volume":"26","author":"R Eastell","year":"2008","unstructured":"Eastell R, Adams JE, Coleman RE et al (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 26:1051\u20131057. https:\/\/doi.org\/10.1200\/JCO.2007.11.0726","journal-title":"J Clin Oncol"},{"key":"340_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/annonc\/mdq541","volume":"22","author":"R Eastell","year":"2011","unstructured":"Eastell R, Adams J, Clack G et al (2011) Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial. Ann Oncol 22:857\u2013862. https:\/\/doi.org\/10.1093\/annonc\/mdq541","journal-title":"Ann Oncol"},{"key":"340_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1590\/0004-282X20180068","volume":"76","author":"SM El-Haggar","year":"2018","unstructured":"El-Haggar SM, Mostafa TM, Allah HMS, Akef GH (2018) Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients. Arq Neuropsiquiatr 76:452\u2013458. https:\/\/doi.org\/10.1590\/0004-282X20180068","journal-title":"Arq Neuropsiquiatr"},{"key":"340_CR48","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1212\/01.WNL.0000125185.74276.D2","volume":"62","author":"KE Ensrud","year":"2004","unstructured":"Ensrud KE, Walczak TS, Blackwell T et al (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62:2051\u20132057","journal-title":"Neurology"},{"key":"340_CR49","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","volume":"58","author":"G Farhat","year":"2002","unstructured":"Farhat G, Yamout B, Mikati MA et al (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:1348\u20131353","journal-title":"Neurology"},{"key":"340_CR50","first-page":"37","volume":"108","author":"J Feldkamp","year":"2000","unstructured":"Feldkamp J, Becker A, Witte OW et al (2000) Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 108:37\u201343","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"340_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1803164","volume":"379","author":"PA Francis","year":"2018","unstructured":"Francis PA, Pagani O, Fleming GF et al (2018) Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med 379:122\u2013137. https:\/\/doi.org\/10.1056\/NEJMoa1803164","journal-title":"N Engl J Med"},{"key":"340_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jpeds.2006.04.060","volume":"149","author":"M Freundlich","year":"2006","unstructured":"Freundlich M (2006) Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic syndrome. J Pediatr 149:383\u2013389. https:\/\/doi.org\/10.1016\/j.jpeds.2006.04.060","journal-title":"J Pediatr"},{"key":"340_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/17446651.2018.1518131","volume":"13","author":"R Fuglsang-Nielsen","year":"2018","unstructured":"Fuglsang-Nielsen R, Starup-Linde J, Gregersen S, Vestergaard P (2018) The effect of meals on bone turnover \u2013 a systematic review with focus on diabetic bone disease. Expert Rev Endocrinol Metab 13:233\u2013249. https:\/\/doi.org\/10.1080\/17446651.2018.1518131","journal-title":"Expert Rev Endocrinol Metab"},{"key":"340_CR54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11606-016-3603-8","volume":"31","author":"O Gajic-Veljanoski","year":"2016","unstructured":"Gajic-Veljanoski O, Phua CW, Shah PS, Cheung AM (2016) Effects of long-term low-molecular-weight heparin on fractures and bone density in non-pregnant adults: a systematic review with meta-analysis. J Gen Intern Med 31:947\u2013957. https:\/\/doi.org\/10.1007\/s11606-016-3603-8","journal-title":"J Gen Intern Med"},{"key":"340_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.thromres.2016.05.016","volume":"143","author":"P Galambosi","year":"2016","unstructured":"Galambosi P, Hiilesmaa V, Ulander V-M et al (2016) Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density. Thromb Res 143:122\u2013126. https:\/\/doi.org\/10.1016\/j.thromres.2016.05.016","journal-title":"Thromb Res"},{"key":"340_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpag.2016.05.012","volume":"29","author":"J Gersten","year":"2016","unstructured":"Gersten J, Hsieh J, Weiss H, Ricciotti NA (2016) Effect of extended 30 \u03bcg ethinyl estradiol with continuous low-dose ethinyl estradiol and cyclic 20 \u03bcg ethinyl estradiol oral contraception on adolescent bone density: a randomized trial. J Pediatr Adolesc Gynecol 29:635\u2013642. https:\/\/doi.org\/10.1016\/j.jpag.2016.05.012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"340_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","volume":"27","author":"LM Giangregorio","year":"2012","unstructured":"Giangregorio LM, Leslie WD, Lix LM et al (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27:301\u2013308. https:\/\/doi.org\/10.1002\/jbmr.556","journal-title":"J Bone Miner Res"},{"key":"340_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1517\/14740338.6.3.267","volume":"6","author":"T Gissel","year":"2007","unstructured":"Gissel T, Poulsen CS, Vestergaard P (2007) Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6:267\u2013278. https:\/\/doi.org\/10.1517\/14740338.6.3.267","journal-title":"Expert Opin Drug Saf"},{"key":"340_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jbmr.5650070514","volume":"7","author":"JB Goerss","year":"1992","unstructured":"Goerss JB, Kim CH, Atkinson EJ et al (1992) Risk of fractures in patients with pernicious anemia. J Bone Miner Res 7:573\u2013579. https:\/\/doi.org\/10.1002\/jbmr.5650070514","journal-title":"J Bone Miner Res"},{"key":"340_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jnci\/djx141","volume":"110","author":"H Goldvaser","year":"2018","unstructured":"Goldvaser H, Barnes TA, \u0160eruga B et al (2018) Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 110:31\u201339. https:\/\/doi.org\/10.1093\/jnci\/djx141","journal-title":"J Natl Cancer Inst"},{"key":"340_CR61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11914-016-0325-0","volume":"14","author":"L Gomez","year":"2016","unstructured":"Gomez L, Stubbs B, Shirazi A et al (2016) Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis. Curr Osteoporos Rep 14:249\u2013259. https:\/\/doi.org\/10.1007\/s11914-016-0325-0","journal-title":"Curr Osteoporos Rep"},{"key":"340_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00774-015-0732-9","volume":"35","author":"F Gotthardt","year":"2017","unstructured":"Gotthardt F, Huber C, Thierfelder C et al (2017) Bone mineral density and its determinants in men with opioid dependence. J Bone Miner Metab 35:99\u2013107. https:\/\/doi.org\/10.1007\/s00774-015-0732-9","journal-title":"J Bone Miner Metab"},{"key":"340_CR63","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jbmr.1874","volume":"28","author":"R G\u00fcerri-Fernandez","year":"2013","unstructured":"G\u00fcerri-Fernandez R, Vestergaard P, Carbonell C et al (2013) HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res 28:1259\u20131263. https:\/\/doi.org\/10.1002\/jbmr.1874","journal-title":"J Bone Miner Res"},{"key":"340_CR64","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00223-016-0109-7","volume":"98","author":"T Hakami","year":"2016","unstructured":"Hakami T, O\u2019Brien TJ, Petty SJ et al (2016) Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health. Calcif Tissue Int 98:556\u2013565. https:\/\/doi.org\/10.1007\/s00223-016-0109-7","journal-title":"Calcif Tissue Int"},{"key":"340_CR65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/thy.2006.16.583","volume":"16","author":"KA Heemstra","year":"2006","unstructured":"Heemstra KA, Hamdy NAT, Romijn JA, Smit JWA (2006) The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. Thyroid 16:583\u2013591. https:\/\/doi.org\/10.1089\/thy.2006.16.583","journal-title":"Thyroid"},{"key":"340_CR66","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","volume":"52","author":"K Heo","year":"2011","unstructured":"Heo K, Rhee Y, Lee HW et al (2011) The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 52:1884\u20131889. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03131.x","journal-title":"Epilepsia"},{"key":"340_CR67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpeds.2018.03.077","volume":"199","author":"JH Heo","year":"2018","unstructured":"Heo JH, Rascati KL, Lopez KN, Moffett BS (2018) Increased fracture risk with furosemide use in children with congenital heart disease. J Pediatr 199:92\u201398.e10. https:\/\/doi.org\/10.1016\/j.jpeds.2018.03.077","journal-title":"J Pediatr"},{"key":"340_CR68","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00198-016-3899-6","volume":"28","author":"AR Hong","year":"2017","unstructured":"Hong AR, Kim JH, Lee KH et al (2017) Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer. Osteoporos Int 28:1413\u20131422. https:\/\/doi.org\/10.1007\/s00198-016-3899-6","journal-title":"Osteoporos Int"},{"key":"340_CR69","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jamda.2016.12.003","volume":"18","author":"S-C Hung","year":"2017","unstructured":"Hung S-C, Lin C-H, Hung H-C et al (2017) Use of selective serotonin reuptake inhibitors and risk of hip fracture in the elderly: a case-control study in Taiwan. J Am Med Dir Assoc 18:350\u2013354. https:\/\/doi.org\/10.1016\/j.jamda.2016.12.003","journal-title":"J Am Med Dir Assoc"},{"key":"340_CR70","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","volume":"12","author":"T Ito","year":"2010","unstructured":"Ito T, Jensen RT (2010) Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep 12:448\u2013457. https:\/\/doi.org\/10.1007\/s11894-010-0141-0","journal-title":"Curr Gastroenterol Rep"},{"key":"340_CR71","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1590\/S0482-50042012000600005","volume":"52","author":"AM Kakehasi","year":"2012","unstructured":"Kakehasi AM, Carvalho AV, Maksud FAN, Barbosa AJA (2012) Serum levels of vitamin B12 are not related to low bone mineral density in postmenopausal Brazilian women. Rev Bras Reumatol 52:863\u2013869","journal-title":"Rev Bras Reumatol"},{"key":"340_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17843286.2018.1512189","volume":"74","author":"Z Killinger","year":"2018","unstructured":"Killinger Z, Gajdarova L, Kuzma M et al (2018) Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-up. Acta Clin Belg 74:121\u2013125. https:\/\/doi.org\/10.1080\/17843286.2018.1512189","journal-title":"Acta Clin Belg"},{"key":"340_CR73","doi-asserted-by":"publisher","first-page":"39562","DOI":"10.1038\/srep39562","volume":"7","author":"SH Kim","year":"2017","unstructured":"Kim SH, Joung JY, Kim S et al (2017) Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: a 12 month-prospective observational study. Sci Rep 7:39562. https:\/\/doi.org\/10.1038\/srep39562","journal-title":"Sci Rep"},{"key":"340_CR74","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","volume":"118","author":"M Kinjo","year":"2005","unstructured":"Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118:1414. https:\/\/doi.org\/10.1016\/j.amjmed.2005.07.033","journal-title":"Am J Med"},{"key":"340_CR75","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.eplepsyres.2013.09.009","volume":"108","author":"DL Koo","year":"2014","unstructured":"Koo DL, Hwang KJ, Han SW et al (2014) Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 108:442\u2013447. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.09.009","journal-title":"Epilepsy Res"},{"key":"340_CR76","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF01806160","volume":"39","author":"B Kristensen","year":"1996","unstructured":"Kristensen B, Ejlertsen B, Mouridsen HT et al (1996) Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat 39:321\u2013326","journal-title":"Breast Cancer Res Treat"},{"key":"340_CR77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/0284186X.2017.1403043","volume":"57","author":"B Kristensen","year":"2018","unstructured":"Kristensen B, Ejlertsen B, Jensen M-B et al (2018) The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study. Acta Oncol 57:141\u2013145. https:\/\/doi.org\/10.1080\/0284186X.2017.1403043","journal-title":"Acta Oncol"},{"key":"340_CR78","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1590\/S0004-27302007000300016","volume":"51","author":"CAM Kulak","year":"2007","unstructured":"Kulak CAM, Borba VZC, Silvado CE et al (2007) Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol 51:466\u2013471","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"340_CR79","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-017-4626-5","volume":"168","author":"ML Kwan","year":"2018","unstructured":"Kwan ML, Yao S, Laurent CA et al (2018) Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat 168:523\u2013530. https:\/\/doi.org\/10.1007\/s10549-017-4626-5","journal-title":"Breast Cancer Res Treat"},{"key":"340_CR80","first-page":"813","volume":"37","author":"OC Kwon","year":"2019","unstructured":"Kwon OC, Oh JS, Hong S et al (2019) Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide. Clin Exp Rheumatol 37:813\u2013819","journal-title":"Clin Exp Rheumatol"},{"key":"340_CR81","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","volume":"28","author":"I Kyvernitakis","year":"2017","unstructured":"Kyvernitakis I, Kostev K, Nassour T et al (2017) The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK. Osteoporos Int 28:291\u2013297. https:\/\/doi.org\/10.1007\/s00198-016-3714-4","journal-title":"Osteoporos Int"},{"key":"340_CR82","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00198-018-4642-2","volume":"29","author":"I Kyvernitakis","year":"2018","unstructured":"Kyvernitakis I, Kostev K, Hadji P (2018) The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer. Osteoporos Int 29:2557\u20132564. https:\/\/doi.org\/10.1007\/s00198-018-4642-2","journal-title":"Osteoporos Int"},{"key":"340_CR83","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","volume":"15","author":"RF Laan","year":"1993","unstructured":"Laan RF, van Riel PL, van de Putte LB et al (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 15:963\u2013968","journal-title":"Ann Intern Med"},{"key":"340_CR84","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1111\/ggi.13087","volume":"17","author":"S-W Lai","year":"2017","unstructured":"Lai S-W, Cheng K-C, Lin C-L, Liao K-F (2017) Furosemide use and acute risk of hip fracture in older people: a nationwide case-control study in Taiwan. Geriatr Gerontol Int 17:2552\u20132558. https:\/\/doi.org\/10.1111\/ggi.13087","journal-title":"Geriatr Gerontol Int"},{"key":"340_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jpag.2016.10.011","volume":"30","author":"HLH Lange","year":"2017","unstructured":"Lange HLH, Manos BE, Gothard MD et al (2017) Bone mineral density and weight changes in adolescents randomized to 3 doses of depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 30:169\u2013175. https:\/\/doi.org\/10.1016\/j.jpag.2016.10.011","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"340_CR86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40801-017-0120-y","volume":"4","author":"MJ Leach","year":"2017","unstructured":"Leach MJ, Pratt NL, Roughead EE (2017) The risk of hip fracture due to mirtazapine exposure when switching antidepressants or using other antidepressants as add-on therapy. Drugs Real World Outcomes 4:247\u2013255. https:\/\/doi.org\/10.1007\/s40801-017-0120-y","journal-title":"Drugs Real World Outcomes"},{"key":"340_CR87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","volume":"8","author":"RH Lee","year":"2010","unstructured":"Lee RH, Lyles KW, Col\u00f3n-Emeric C (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 8:34\u201346. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.02.003","journal-title":"Am J Geriatr Pharmacother"},{"key":"340_CR88","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00404-016-4184-9","volume":"294","author":"D-Y Lee","year":"2016","unstructured":"Lee D-Y, Lee J-Y, Seo J-W et al (2016) Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Arch Gynecol Obstet 294:1257\u20131263. https:\/\/doi.org\/10.1007\/s00404-016-4184-9","journal-title":"Arch Gynecol Obstet"},{"key":"340_CR89","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00198-016-3881-3","volume":"28","author":"S-H Lee","year":"2017","unstructured":"Lee S-H, Hsu W-T, Lai C-C et al (2017) Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis. Osteoporos Int 28:1167\u20131178. https:\/\/doi.org\/10.1007\/s00198-016-3881-3","journal-title":"Osteoporos Int"},{"key":"340_CR90","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0304-4165(79)90114-4","volume":"584","author":"G Lenaers-Claeys","year":"1979","unstructured":"Lenaers-Claeys G, Vaes G (1979) Collagenase, procollagenase and bone resorption. Effects of heparin, parathyroid hormone and calcitonin. Biochim Biophys Acta 584:375\u2013388","journal-title":"Biochim Biophys Acta"},{"key":"340_CR91","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","volume":"117","author":"M Leuschner","year":"1999","unstructured":"Leuschner M, Maier KP, Schlichting J et al (1999) Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 117:918\u2013925","journal-title":"Gastroenterology"},{"key":"340_CR92","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/ageing\/afi133","volume":"34","author":"LS Lim","year":"2005","unstructured":"Lim LS, Fink HA, Kuskowski MA et al (2005) Diuretic use and bone mineral density in older USA men: the osteoporotic fractures in men (MrOS) study. Age Ageing 34:504\u2013507. https:\/\/doi.org\/10.1093\/ageing\/afi133","journal-title":"Age Ageing"},{"key":"340_CR93","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/archinte.168.7.735","volume":"168","author":"LS Lim","year":"2008","unstructured":"Lim LS, Fink HA, Kuskowski MA et al (2008) Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 168:735\u2013740. https:\/\/doi.org\/10.1001\/archinte.168.7.735","journal-title":"Arch Intern Med"},{"key":"340_CR94","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20176374","volume":"50","author":"CA Lima","year":"2017","unstructured":"Lima CA, Lyra AC, Mendes CMC et al (2017) Bone mineral density and inflammatory bowel disease severity. Braz J Med Biol Res 50:e6374. https:\/\/doi.org\/10.1590\/1414-431X20176374","journal-title":"Braz J Med Biol Res"},{"key":"340_CR95","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/JOE-18-0316","volume":"239","author":"V Lionikaite","year":"2018","unstructured":"Lionikaite V, Gustafsson KL, Westerlund A et al (2018) Clinically relevant doses of vitamin A decrease cortical bone mass in mice. J Endocrinol 239:389\u2013402. https:\/\/doi.org\/10.1530\/JOE-18-0316","journal-title":"J Endocrinol"},{"key":"340_CR96","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","volume":"218","author":"J Liu","year":"2019","unstructured":"Liu J, Li X, Fan L et al (2019) Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis. Life Sci 218:213\u2013223. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.058","journal-title":"Life Sci"},{"key":"340_CR97","doi-asserted-by":"publisher","first-page":"CD009849","DOI":"10.1002\/14651858.CD009849.pub3","volume":"7","author":"LM Lopez","year":"2015","unstructured":"Lopez LM, Chen M, Mullins Long S et al (2015) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 7:CD009849. https:\/\/doi.org\/10.1002\/14651858.CD009849.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"340_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.breast.2016.02.007","volume":"27","author":"C Markopoulos","year":"2016","unstructured":"Markopoulos C, Koukouras D, Venizelos V et al (2016) Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: results of the POCHARBI trial conducted by the Hellenic Society of Breast Surgeons. Breast 27:27\u201334. https:\/\/doi.org\/10.1016\/j.breast.2016.02.007","journal-title":"Breast"},{"key":"340_CR99","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00586-017-5401-3","volume":"27","author":"K Masamoto","year":"2018","unstructured":"Masamoto K, Otsuki B, Fujibayashi S et al (2018) Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis. Eur Spine J 27:406\u2013415. https:\/\/doi.org\/10.1007\/s00586-017-5401-3","journal-title":"Eur Spine J"},{"key":"340_CR100","first-page":"17","volume":"57","author":"N Masunari","year":"2008","unstructured":"Masunari N, Fujiwara S, Nakata Y et al (2008) Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese. Hiroshima J Med Sci 57:17\u201325","journal-title":"Hiroshima J Med Sci"},{"key":"340_CR101","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.urology.2004.03.012","volume":"64","author":"Y Miyaji","year":"2004","unstructured":"Miyaji Y, Saika T, Yamamoto Y et al (2004) Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer. Urology 64:128\u2013131. https:\/\/doi.org\/10.1016\/j.urology.2004.03.012","journal-title":"Urology"},{"key":"340_CR102","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/13625187.2014.924098","volume":"19","author":"W Modesto","year":"2014","unstructured":"Modesto W, Bahamondes MV, Silva dos Santos P et al (2014) Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate. Eur J Contracept Reprod Health Care 19:244\u2013249. https:\/\/doi.org\/10.3109\/13625187.2014.924098","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"340_CR103","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MCP.0000000000000554","volume":"25","author":"J-Y Moon","year":"2019","unstructured":"Moon J-Y, Sin DD (2019) Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations. Curr Opin Pulm Med 25:165\u2013172. https:\/\/doi.org\/10.1097\/MCP.0000000000000554","journal-title":"Curr Opin Pulm Med"},{"key":"340_CR104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000229309","volume":"62","author":"MJ Moro-Alvarez","year":"2009","unstructured":"Moro-Alvarez MJ, D\u00edaz Curiel M, de la Piedra C et al (2009) Bone disease induced by phenytoin therapy: clinical and experimental study. Eur Neurol 62:219\u2013230. https:\/\/doi.org\/10.1159\/000229309","journal-title":"Eur Neurol"},{"key":"340_CR105","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00380-017-0950-2","volume":"32","author":"S Namba","year":"2017","unstructured":"Namba S, Yamaoka-Tojo M, Kakizaki R et al (2017) Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessel 32:977\u2013982. https:\/\/doi.org\/10.1007\/s00380-017-0950-2","journal-title":"Heart Vessel"},{"key":"340_CR106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.11005\/jbm.2018.25.3.141","volume":"25","author":"Y Nassar","year":"2018","unstructured":"Nassar Y, Richter S (2018) Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis. J Bone Metab 25:141\u2013151. https:\/\/doi.org\/10.11005\/jbm.2018.25.3.141","journal-title":"J Bone Metab"},{"key":"340_CR107","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-5198(19)31427-1","volume":"74","author":"M Nishiyama","year":"1997","unstructured":"Nishiyama M, Itoh F, Ujiie A (1997) Low-molecular-weight heparin (dalteparin) demonstrated a weaker effect on rat bone metabolism compared with heparin. Jpn J Pharmacol 74:59\u201368","journal-title":"Jpn J Pharmacol"},{"key":"340_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11934-016-0634-y","volume":"17","author":"TK O\u2019Rourke","year":"2016","unstructured":"O\u2019Rourke TK, Wosnitzer MS (2016) Opioid-induced androgen deficiency (OPIAD): diagnosis, management, and literature review. Curr Urol Rep 17:76. https:\/\/doi.org\/10.1007\/s11934-016-0634-y","journal-title":"Curr Urol Rep"},{"key":"340_CR109","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bone.2018.02.007","volume":"110","author":"OA Oshagbemi","year":"2018","unstructured":"Oshagbemi OA, Burden AM, Shudofsky KN et al (2018) Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease. Bone 110:238\u2013243. https:\/\/doi.org\/10.1016\/j.bone.2018.02.007","journal-title":"Bone"},{"key":"340_CR110","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","volume":"70","author":"AM Pack","year":"2008","unstructured":"Pack AM, Morrell MJ, Randall A et al (2008) Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70:1586\u20131593. https:\/\/doi.org\/10.1212\/01.wnl.0000310981.44676.de","journal-title":"Neurology"},{"key":"340_CR111","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00198-015-3123-0","volume":"26","author":"A Palermo","year":"2015","unstructured":"Palermo A, D\u2019Onofrio L, Eastell R et al (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int 26:2073\u20132089. https:\/\/doi.org\/10.1007\/s00198-015-3123-0","journal-title":"Osteoporos Int"},{"key":"340_CR112","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S8756-3282(01)00610-X","volume":"29","author":"D Patschan","year":"2001","unstructured":"Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498\u2013505","journal-title":"Bone"},{"key":"340_CR113","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/1871530318666180423121833","volume":"18","author":"V Pavlova","year":"2018","unstructured":"Pavlova V, Filipova E, Uzunova K et al (2018) Pioglitazone therapy and fractures: systematic review and meta-analysis. Endocr Metab Immune Disord Drug Targets 18:502\u2013507. https:\/\/doi.org\/10.2174\/1871530318666180423121833","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"340_CR114","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bone.2018.08.013","volume":"116","author":"MJ P\u00e9rez-S\u00e1ez","year":"2018","unstructured":"P\u00e9rez-S\u00e1ez MJ, Herrera S, Prieto-Alhambra D et al (2018) Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: a pilot prospective cohort study. Bone 116:290\u2013294. https:\/\/doi.org\/10.1016\/j.bone.2018.08.013","journal-title":"Bone"},{"key":"340_CR115","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0037-1612970","volume":"87","author":"V Pettil\u00e4","year":"2002","unstructured":"Pettil\u00e4 V, Leinonen P, Markkola A et al (2002) Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 87:182\u2013186","journal-title":"Thromb Haemost"},{"key":"340_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/epi.12049","volume":"54","author":"K Phabphal","year":"2013","unstructured":"Phabphal K, Geater A, Limapichart K et al (2013) The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin. Epilepsia 54:249\u2013255. https:\/\/doi.org\/10.1111\/epi.12049","journal-title":"Epilepsia"},{"key":"340_CR117","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/QAI.0000000000000112","volume":"66","author":"D Prieto-Alhambra","year":"2014","unstructured":"Prieto-Alhambra D, G\u00fcerri-Fern\u00e1ndez R, de Vries F et al (2014) HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study. J Acquir Immune Defic Syndr 66:90\u201395. https:\/\/doi.org\/10.1097\/QAI.0000000000000112","journal-title":"J Acquir Immune Defic Syndr"},{"key":"340_CR118","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.19082\/3257","volume":"8","author":"A Rahimdel","year":"2016","unstructured":"Rahimdel A, Dehghan A, Moghadam MA, Ardekani AM (2016) Relationship between bone density and biochemical markers of bone among two groups taking carbamazepine and sodium valproate for epilepsy in comparison with healthy individuals in Yazd. Electron Physician 8:3257\u20133265. https:\/\/doi.org\/10.19082\/3257","journal-title":"Electron Physician"},{"key":"340_CR119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bone.2016.05.003","volume":"89","author":"PH Rauma","year":"2016","unstructured":"Rauma PH, Honkanen RJ, Williams LJ et al (2016) Effects of antidepressants on postmenopausal bone loss \u2013 a 5-year longitudinal study from the OSTPRE cohort. Bone 89:25\u201331. https:\/\/doi.org\/10.1016\/j.bone.2016.05.003","journal-title":"Bone"},{"key":"340_CR120","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1046\/j.1365-2362.2001.00883.x","volume":"31","author":"L Rejnmark","year":"2001","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L et al (2001) Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Investig 31:764\u2013772","journal-title":"Eur J Clin Investig"},{"key":"340_CR121","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1359\/JBMR.040209","volume":"19","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Buus NH, Vestergaard P et al (2004a) Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19:737\u2013744. https:\/\/doi.org\/10.1359\/JBMR.040209","journal-title":"J Bone Miner Res"},{"key":"340_CR122","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00198-004-1618-1","volume":"15","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Vestergaard P, Charles P et al (2004b) No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int 15:872\u2013880. https:\/\/doi.org\/10.1007\/s00198-004-1618-1","journal-title":"Osteoporos Int"},{"key":"340_CR123","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","volume":"76","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167\u2013175. https:\/\/doi.org\/10.1007\/s00223-004-0084-2","journal-title":"Calcif Tissue Int"},{"key":"340_CR124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","volume":"259","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006a) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117\u2013124. https:\/\/doi.org\/10.1111\/j.1365-2796.2005.01585.x","journal-title":"J Intern Med"},{"key":"340_CR125","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00223-006-0024-4","volume":"79","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006b) Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int 79:27\u201336. https:\/\/doi.org\/10.1007\/s00223-006-0024-4","journal-title":"Calcif Tissue Int"},{"key":"340_CR126","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ijcard.2006.07.022","volume":"118","author":"L Rejnmark","year":"2007","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 118:338\u2013344. https:\/\/doi.org\/10.1016\/j.ijcard.2006.07.022","journal-title":"Int J Cardiol"},{"key":"340_CR127","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/BF01955180","volume":"155","author":"G Saggese","year":"1996","unstructured":"Saggese G, Bertelloni S, Baroncelli GI et al (1996) Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study. Eur J Pediatr 155:452\u2013457","journal-title":"Eur J Pediatr"},{"key":"340_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1542-3565(04)00662-7","volume":"3","author":"EJ Schoon","year":"2005","unstructured":"Schoon EJ, Bollani S, Mills PR et al (2005) Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn\u2019s disease. Clin Gastroenterol Hepatol 3:113\u2013121","journal-title":"Clin Gastroenterol Hepatol"},{"key":"340_CR129","doi-asserted-by":"publisher","first-page":"E1373","DOI":"10.3390\/ijerph15071373","volume":"15","author":"JU Schweiger","year":"2018","unstructured":"Schweiger JU, Schweiger U, H\u00fcppe M et al (2018) The use of antidepressive agents and bone mineral density in women: a meta-analysis. Int J Environ Res Public Health 15:E1373. https:\/\/doi.org\/10.3390\/ijerph15071373","journal-title":"Int J Environ Res Public Health"},{"key":"340_CR130","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/joim.12688","volume":"283","author":"D Segna","year":"2018","unstructured":"Segna D, Bauer DC, Feller M et al (2018) Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. J Intern Med 283:56\u201372. https:\/\/doi.org\/10.1111\/joim.12688","journal-title":"J Intern Med"},{"key":"340_CR131","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","volume":"37","author":"RD Sheth","year":"2007","unstructured":"Sheth RD, Hermann BP (2007) Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 37:250\u2013254. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2007.05.018","journal-title":"Pediatr Neurol"},{"key":"340_CR132","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jocd.2016.07.008","volume":"19","author":"B Shiek Ahmad","year":"2016","unstructured":"Shiek Ahmad B, O\u2019Brien TJ, Gorelik A et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom 19:450\u2013456. https:\/\/doi.org\/10.1016\/j.jocd.2016.07.008","journal-title":"J Clin Densitom"},{"key":"340_CR133","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11255-012-0264-3","volume":"45","author":"C Shimizu","year":"2013","unstructured":"Shimizu C, Fujita T, Fuke Y et al (2013) Effects of cyclosporine on bone mineral density in patients with glucocorticoid-dependent nephrotic syndrome in remission. Int Urol Nephrol 45:803\u2013808. https:\/\/doi.org\/10.1007\/s11255-012-0264-3","journal-title":"Int Urol Nephrol"},{"key":"340_CR134","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1097\/01.ju.0000127738.94221.da","volume":"171","author":"PR Sieber","year":"2004","unstructured":"Sieber PR, Keiller DL, Kahnoski RJ et al (2004) Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. J Urol 171:2272\u20132276, quiz 2435","journal-title":"J Urol"},{"key":"340_CR135","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.2004.01.174","volume":"22","author":"MR Smith","year":"2004","unstructured":"Smith MR, Goode M, Zietman AL et al (2004) Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol 22:2546\u20132553. https:\/\/doi.org\/10.1200\/JCO.2004.01.174","journal-title":"J Clin Oncol"},{"key":"340_CR136","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","volume":"23","author":"MR Smith","year":"2005","unstructured":"Smith MR, Lee WC, Brandman J et al (2005) Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol 23:7897\u20137903. https:\/\/doi.org\/10.1200\/JCO.2004.00.6908","journal-title":"J Clin Oncol"},{"key":"340_CR137","first-page":"71","volume":"112","author":"E Stenova","year":"2011","unstructured":"Stenova E, Steno B, Killinger Z et al (2011) Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study. Bratisl Lek Listy 112:71\u201376","journal-title":"Bratisl Lek Listy"},{"key":"340_CR138","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1677\/JOE-07-0119","volume":"194","author":"T Sugiyama","year":"2007","unstructured":"Sugiyama T, Takaki T, Sakanaka K et al (2007) Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli. J Endocrinol 194:213\u2013222. https:\/\/doi.org\/10.1677\/JOE-07-0119","journal-title":"J Endocrinol"},{"key":"340_CR139","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5455\/medarh.2018.72.262-266","volume":"72","author":"EM Suljic","year":"2018","unstructured":"Suljic EM, Mehicevic A, Mahmutbegovic N (2018) Effect of long-term carbamazepine therapy on bone health. Med Arch 72:262\u2013266. https:\/\/doi.org\/10.5455\/medarh.2018.72.262-266","journal-title":"Med Arch"},{"key":"340_CR140","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/10428194.2016.1233543","volume":"58","author":"P Svendsen","year":"2017","unstructured":"Svendsen P, Shekhrajka N, Nielsen KL et al (2017) R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients. Leuk Lymphoma 58:1105\u20131113. https:\/\/doi.org\/10.1080\/10428194.2016.1233543","journal-title":"Leuk Lymphoma"},{"key":"340_CR141","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/thorax.56.4.272","volume":"56","author":"AE Tattersfield","year":"2001","unstructured":"Tattersfield AE, Town GI, Johnell O et al (2001) Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 56:272\u2013278","journal-title":"Thorax"},{"key":"340_CR142","first-page":"869","volume":"58","author":"F Tr\u00e9molli\u00e8res","year":"1991","unstructured":"Tr\u00e9molli\u00e8res F, Pouill\u00e8s JM, Louvet JP, Ribot C (1991) Transitory bone loss during substitution treatment for hypothyroidism. Results of a two year prospective study. Rev Rhum Mal Osteoartic 58:869\u2013875","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"340_CR143","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001967","volume":"94","author":"P-T Tseng","year":"2015","unstructured":"Tseng P-T, Chen Y-W, Yeh P-Y et al (2015) Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA. Medicine (Baltimore) 94:e1967. https:\/\/doi.org\/10.1097\/MD.0000000000001967","journal-title":"Medicine (Baltimore)"},{"key":"340_CR144","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1759720X18759291","volume":"10","author":"OL Tseng","year":"2018","unstructured":"Tseng OL, Spinelli JJ, Gotay CC et al (2018) Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis. Ther Adv Musculoskelet Dis 10:71\u201390. https:\/\/doi.org\/10.1177\/1759720X18759291","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"340_CR145","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0169-6009(08)80078-5","volume":"22","author":"HE van der Wiel","year":"1993","unstructured":"van der Wiel HE, Lips P, Huijgens PC, Netelenbos JC (1993) Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover. Bone Miner 22:27\u201332","journal-title":"Bone Miner"},{"key":"340_CR146","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP van Staa","year":"2003","unstructured":"van Staa TP, Laan RF, Barton IP et al (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229. https:\/\/doi.org\/10.1002\/art.11283","journal-title":"Arthritis Rheum"},{"key":"340_CR147","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk \u2013 a meta-analysis. Acta Neurol Scand 112:277\u2013286. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00474.x","journal-title":"Acta Neurol Scand"},{"key":"340_CR148","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 18:427\u2013444. https:\/\/doi.org\/10.1007\/s00198-006-0253-4","journal-title":"Osteoporos Int"},{"key":"340_CR149","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/157488608785699522","volume":"3","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P (2008a) Skeletal effects of drugs to treat cancer. Curr Drug Saf 3:173\u2013177","journal-title":"Curr Drug Saf"},{"key":"340_CR150","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/157488608785699504","volume":"3","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P (2008b) Pain-relief medication and risk of fractures. Curr Drug Saf 3:199\u2013203","journal-title":"Curr Drug Saf"},{"key":"340_CR151","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrendo.2014.232","volume":"11","author":"P Vestergaard","year":"2015","unstructured":"Vestergaard P (2015a) Bone: fracture risk in the JUPITER trial--statin treatment or not? Nat Rev Endocrinol 11:135\u2013136. https:\/\/doi.org\/10.1038\/nrendo.2014.232","journal-title":"Nat Rev Endocrinol"},{"key":"340_CR152","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40272-014-0115-z","volume":"17","author":"P Vestergaard","year":"2015","unstructured":"Vestergaard P (2015b) Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs 17:141\u2013150. https:\/\/doi.org\/10.1007\/s40272-014-0115-z","journal-title":"Paediatr Drugs"},{"key":"340_CR153","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid 13:585\u2013593. https:\/\/doi.org\/10.1089\/105072503322238854","journal-title":"Thyroid"},{"key":"340_CR154","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/thy.2000.10.335","volume":"10","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Weeke J, Hoeck HC et al (2000) Fractures in patients with primary idiopathic hypothyroidism. Thyroid 10:335\u2013340. https:\/\/doi.org\/10.1089\/thy.2000.10.335","journal-title":"Thyroid"},{"key":"340_CR155","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","volume":"56","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, J\u00f8rgensen JOL, Hagen C et al (2002) Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study. Clin Endocrinol 56:159\u2013167","journal-title":"Clin Endocrinol"},{"key":"340_CR156","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","volume":"45","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of antiepileptic drugs. Epilepsia 45:1330\u20131337. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.18804.x","journal-title":"Epilepsia"},{"key":"340_CR157","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","volume":"257","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257:374\u2013384. https:\/\/doi.org\/10.1111\/j.1365-2796.2005.01467.x","journal-title":"J Intern Med"},{"key":"340_CR158","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006a) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79:76\u201383. https:\/\/doi.org\/10.1007\/s00223-006-0021-7","journal-title":"Calcif Tissue Int"},{"key":"340_CR159","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00223-006-0060-0","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006b) Methotrexate, azathioprine, cyclosporine, and risk of fracture. Calcif Tissue Int 79:69\u201375. https:\/\/doi.org\/10.1007\/s00223-006-0060-0","journal-title":"Calcif Tissue Int"},{"key":"340_CR160","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00223-006-0020-8","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006c) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84\u201394. https:\/\/doi.org\/10.1007\/s00223-006-0020-8","journal-title":"Calcif Tissue Int"},{"key":"340_CR161","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006d) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807\u2013816. https:\/\/doi.org\/10.1007\/s00198-005-0065-y","journal-title":"Osteoporos Int"},{"key":"340_CR162","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1378\/chest.07-1092","volume":"132","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132:1599\u20131607. https:\/\/doi.org\/10.1378\/chest.07-1092","journal-title":"Chest"},{"key":"340_CR163","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","volume":"78","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008a) The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception 78:459\u2013464. https:\/\/doi.org\/10.1016\/j.contraception.2008.07.014","journal-title":"Contraception"},{"key":"340_CR164","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.contraception.2008.06.010","volume":"78","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008b) Fracture risk in very young women using combined oral contraceptives. Contraception 78:358\u2013364. https:\/\/doi.org\/10.1016\/j.contraception.2008.06.010","journal-title":"Contraception"},{"key":"340_CR165","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008c) Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 82:249\u2013257. https:\/\/doi.org\/10.1007\/s00223-008-9124-7","journal-title":"Calcif Tissue Int"},{"key":"340_CR166","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00223-008-9132-7","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008d) Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int 82:334\u2013340. https:\/\/doi.org\/10.1007\/s00223-008-9132-7","journal-title":"Calcif Tissue Int"},{"key":"340_CR167","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00223-007-9099-9","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008e) Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 82:92\u2013101. https:\/\/doi.org\/10.1007\/s00223-007-9099-9","journal-title":"Calcif Tissue Int"},{"key":"340_CR168","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00223-007-9095-0","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008f) Anxiolytics and sedatives and risk of fractures: effects of half-life. Calcif Tissue Int 82:34\u201343. https:\/\/doi.org\/10.1007\/s00223-007-9095-0","journal-title":"Calcif Tissue Int"},{"key":"340_CR169","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/archdermatol.2010.59","volume":"146","author":"P Vestergaard","year":"2010","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2010) High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol 146:478\u2013482. https:\/\/doi.org\/10.1001\/archdermatol.2010.59","journal-title":"Arch Dermatol"},{"key":"340_CR170","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","volume":"23","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Hermann P, Jensen J-EB et al (2012) Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 23:1255\u20131265. https:\/\/doi.org\/10.1007\/s00198-011-1692-0","journal-title":"Osteoporos Int"},{"key":"340_CR171","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","volume":"24","author":"P Vestergaard","year":"2013","unstructured":"Vestergaard P, Prieto-Alhambra D, Javaid MK, Cooper C (2013) Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int 24:671\u2013680. https:\/\/doi.org\/10.1007\/s00198-012-2043-5","journal-title":"Osteoporos Int"},{"key":"340_CR172","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","volume":"104","author":"VK Wadhwa","year":"2009","unstructured":"Wadhwa VK, Weston R, Mistry R, Parr NJ (2009) Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int 104:800\u2013805. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08483.x","journal-title":"BJU Int"},{"key":"340_CR173","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/j.1464-410X.2010.09726.x","volume":"107","author":"VK Wadhwa","year":"2011","unstructured":"Wadhwa VK, Weston R, Parr NJ (2011) Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer. BJU Int 107:1923\u20131929. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09726.x","journal-title":"BJU Int"},{"key":"340_CR174","unstructured":"WHOCC (n.d.) ATC\/DDD Index. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 25 Feb 2019"},{"key":"340_CR175","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.bone.2011.03.435","volume":"48","author":"LJ Williams","year":"2011","unstructured":"Williams LJ, Pasco JA, Henry MJ et al (2011) Paracetamol (acetaminophen) use, fracture and bone mineral density. Bone 48:1277\u20131281. https:\/\/doi.org\/10.1016\/j.bone.2011.03.435","journal-title":"Bone"},{"key":"340_CR176","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","volume":"355","author":"CA Wong","year":"2000","unstructured":"Wong CA, Walsh LJ, Smith CJ et al (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399\u20131403. https:\/\/doi.org\/10.1016\/S0140-6736(00)02138-3","journal-title":"Lancet"},{"key":"340_CR177","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.1813","volume":"28","author":"Q Wu","year":"2013","unstructured":"Wu Q, Qu W, Crowell MD et al (2013) Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. J Bone Miner Res 28:753\u2013763. https:\/\/doi.org\/10.1002\/jbmr.1813","journal-title":"J Bone Miner Res"},{"key":"340_CR178","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fphar.2018.01517","volume":"9","author":"Y Ye","year":"2018","unstructured":"Ye Y, Zhao C, Liang J et al (2018) Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk. Front Pharmacol 9:1517. https:\/\/doi.org\/10.3389\/fphar.2018.01517","journal-title":"Front Pharmacol"},{"key":"340_CR179","first-page":"96","volume":"12","author":"J Zhang","year":"2010","unstructured":"Zhang J, Wang K-X, Wei Y et al (2010) Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy. Zhongguo Dang Dai Er Ke Za Zhi 12:96\u201398","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"340_CR180","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.3760\/cma.j.issn.0366-6999.20130885","volume":"126","author":"M-H Zhang","year":"2013","unstructured":"Zhang M-H, Zhang W, Zhang A-D et al (2013) Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women. Chin Med J 126:4043\u20134047","journal-title":"Chin Med J"},{"key":"340_CR181","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/ijerph14091043","volume":"14","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhang R, Moore JB et al (2017) The effect of vitamin A on fracture risk: a meta-analysis of cohort studies. Int J Environ Res Public Health 14:1043. https:\/\/doi.org\/10.3390\/ijerph14091043","journal-title":"Int J Environ Res Public Health"},{"key":"340_CR182","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","volume":"68","author":"Z-N Zhu","year":"2014","unstructured":"Zhu Z-N, Jiang Y-F, Ding T (2014) Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. Bone 68:115\u2013123. https:\/\/doi.org\/10.1016\/j.bone.2014.08.010","journal-title":"Bone"},{"key":"340_CR183","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1385\/MO:21:2:117","volume":"21","author":"J Zidan","year":"2004","unstructured":"Zidan J, Keidar Z, Basher W, Israel O (2004) Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer. Med Oncol 21:117\u2013121. https:\/\/doi.org\/10.1385\/MO:21:2:117","journal-title":"Med Oncol"}],"container-title":["Handbook of Experimental Pharmacology","Bone Regulators and Osteoporosis Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T08:58:04Z","timestamp":1722243484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030573775","9783030573782"],"references-count":183,"URL":"https:\/\/doi.org\/10.1007\/164_2019_340","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"31 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}